If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
3
Followers on Owler
Urigen
is a pharmaceutical company that engages in developing and commercializing non-oncological urology treatments...
Read more
Overview
Competitors
Funding
News & Insights
Urigen
is a pharmaceutical company that engages in developing and commercializing non-oncological urology treatments...
Read more
President & CEO
Dan Vickery
CEO Approval Rating
74/100
Weigh In
1997
New Brunswick
New Jersey
New York Metropolitan Area
Private
Pharmaceuticals & Biotechnology
Pharmaceuticals
2834
NAICS listing
http://urigen.com/
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$5.9M
News
Latest News
Nov 19, 2018
BioPortfolio
Urigen: Urigen Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13112018 Prices from USD $250
Aug 25, 2018
BioPortfolio
Urigen: Urigen Pharmaceuticals Inc Strategic SWOT Analysis Review Report Updated 25042018 Prices from USD $125
Nov 29, 2017
BioPortfolio
Urigen: Urigen Pharmaceuticals Inc Strategic SWOT Analysis Review Report Updated 07112017 Prices from USD $125
Nov 24, 2017
BioPortfolio
Urigen: Urigen Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 08112017 Prices from USD $250
Mar 29, 2017
BioPortfolio
Urigen: Urigen Pharmaceuticals Inc URGP Pharmaceuticals Healthcare Deals and Alliances Profile Updated 22032017 Prices from USD $250
Jan 14, 2017
BioPortfolio
Urigen: Urigen Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Jun 15, 2015
PR-INSIDE.COM
Press Release: Urigen : Urigen Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Jul 07, 2014
BIOSPACE
Urigen: Urigen Pharmaceuticals, Inc. Announces Closing Of Restructuring, And Post-Close Addition Of New Board Member, And Restructuring Of Bridge Note
Jul 03, 2014
MARKETWIRED
Press Release: Urigen : Urigen Pharmaceuticals Announces Closing of Restructuring, and Post-Close Addition of New Board Member, and Restructuring of Bridge Note
May 30, 2014
BIOSPACE
Urigen: Urigen Pharmaceuticals, Inc. Announces Results Of Shareholder Meeting Vote On Proposed Restructuring
Follow and Get Alerts
Urigen Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 11 + competitors
Trending Companies